Table 2

Predictive risk of Ang2 plasma levels and main established CLL prognostic factors in relation to TTFT and overall survival (univariate Cox models)

FactorTTFT
Overall survival
HR95% CIPHR95% CIP
Ang2 level ≥ 2459 pg/mL 2.437 1.621-3.664 < .001 3.566 1.496-8.499 .004 
Binet stages B-C 8.883 5.527-14.277 < .001 6.860 2.743-17.155 < .001 
IGHV mutation < 2% 4.342 2.792-6.754 < .001 3.749 1.453-9.675 .006 
CD38 expression ≥ 30% 2.647 1.738-4.029 < .001 3.178 1.330-7.592 .009 
ZAP-70 expression ≥ 20% 2.422 1.577-3.720 < .001 2.666 0.950-7.486 .062 
CD49d expression ≥ 30% 2.903 1.715-4.913 < .001 7.019 2.179-22.607 .001 
Intermediate/high FISH risk* 4.215 2.766-6.423 < .001 2.531 0.995-6.435 .050 
β2-Microglobulin ≥ 2.2 mg/L 2.347 1.515-3.636 < .001 17.727 2.369-132.633 .005 
Diffuse BM pattern 3.750 2.017-6.972 < .001 4.907 1.552-15.516 .007 
FactorTTFT
Overall survival
HR95% CIPHR95% CIP
Ang2 level ≥ 2459 pg/mL 2.437 1.621-3.664 < .001 3.566 1.496-8.499 .004 
Binet stages B-C 8.883 5.527-14.277 < .001 6.860 2.743-17.155 < .001 
IGHV mutation < 2% 4.342 2.792-6.754 < .001 3.749 1.453-9.675 .006 
CD38 expression ≥ 30% 2.647 1.738-4.029 < .001 3.178 1.330-7.592 .009 
ZAP-70 expression ≥ 20% 2.422 1.577-3.720 < .001 2.666 0.950-7.486 .062 
CD49d expression ≥ 30% 2.903 1.715-4.913 < .001 7.019 2.179-22.607 .001 
Intermediate/high FISH risk* 4.215 2.766-6.423 < .001 2.531 0.995-6.435 .050 
β2-Microglobulin ≥ 2.2 mg/L 2.347 1.515-3.636 < .001 17.727 2.369-132.633 .005 
Diffuse BM pattern 3.750 2.017-6.972 < .001 4.907 1.552-15.516 .007 
*

Intermediate/high-risk cytogenetic indicates 11q−, 17p−, or trisomy 12.

Close Modal

or Create an Account

Close Modal
Close Modal